List of Suppliers' Film Formers Plasticizers Excipients Application used in MolPort-001-738-728 on PharmaCompass.com

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

10 RELATED EXCIPIENT COMPANIES

22EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 113617-63-3, Orbax, Nsc-758614, 660932tpy6, 1-cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid, 3-quinolinecarboxylic acid, 1-cyclopropyl-7-[(3r,5s)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-1,4-dihydro-4-oxo-, rel-
Molecular Formula
C19H20F3N3O3
Molecular Weight
395.4  g/mol
InChI Key
QIPQASLPWJVQMH-DTORHVGOSA-N
FDA UNII
660932TPY6

Orbifloxacin
Orbifloxacin is a fluoroquinolone antibiotic. It is marketed by Schering-Plough Animal Health and approved for certain infections in dogs.
1 2D Structure

Orbifloxacin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid
2.1.2 InChI
InChI=1S/C19H20F3N3O3/c1-8-5-24(6-9(2)23-8)17-14(21)13(20)12-16(15(17)22)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6H2,1-2H3,(H,27,28)/t8-,9+
2.1.3 InChI Key
QIPQASLPWJVQMH-DTORHVGOSA-N
2.1.4 Canonical SMILES
CC1CN(CC(N1)C)C2=C(C3=C(C(=C2F)F)C(=O)C(=CN3C4CC4)C(=O)O)F
2.1.5 Isomeric SMILES
C[C@@H]1CN(C[C@@H](N1)C)C2=C(C3=C(C(=C2F)F)C(=O)C(=CN3C4CC4)C(=O)O)F
2.2 Other Identifiers
2.2.1 UNII
660932TPY6
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 113617-63-3

2. Orbax

3. Nsc-758614

4. 660932tpy6

5. 1-cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic Acid

6. 3-quinolinecarboxylic Acid, 1-cyclopropyl-7-[(3r,5s)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-1,4-dihydro-4-oxo-, Rel-

7. Ncgc00160518-01

8. Dsstox_cid_26201

9. Dsstox_rid_81432

10. Dsstox_gsid_46201

11. 1-cyclopropyl-7-((3s,5r)-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

12. 1-cyclopropyl-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic Acid

13. Smr000544203

14. Cp-104354

15. Orbifloxacin [inn]

16. Cas-113617-63-3

17. Sr-01000790054

18. Orbifloxacin [usp:inn:ban]

19. Mfcd00864858

20. Unii-660932tpy6

21. 1-cyclopropyl-7-((3r,5s)-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

22. Specplus_000366

23. Cp 104354

24. Orbifloxacin (usp/inn)

25. Orbifloxacin [mi]

26. Orbax [veterinary] (tn)

27. Orbifloxacin [jan]

28. Orbifloxacin Impurity Mixture

29. Orbifloxacin [mart.]

30. Mls000766847

31. Mls001216436

32. Divk1c_006462

33. Orbifloxacin [usp-rs]

34. Schembl125116

35. Chembl295433

36. Dtxsid7046201

37. Kbio1_001406

38. Orbifloxacin [green Book]

39. Chebi:183823

40. Hms2875g03

41. Hms3264m13

42. Pharmakon1600-01503711

43. Orbifloxacin [usp Impurity]

44. Bcp18829

45. Hy-b0915

46. Rkl10078

47. Zinc3882891

48. Orbifloxacin [usp Monograph]

49. Tox21_111867

50. Nsc758614

51. S4150

52. Akos015969739

53. Tox21_111867_1

54. Ccg-213832

55. Cs-4384

56. Db11443

57. Ks-5013

58. Nsc 758614

59. Orbifloxacin 100 Microg/ml In Methanol

60. Ncgc00160518-02

61. Ncgc00160518-03

62. Ncgc00160518-04

63. 1-cyclopropyl-5,6,8-trifluoro-1,4-dihydro-7-(cis-3,5-dimethyl-1-piperazinyl)-4-oxo-quinoline-3-carboxylic Acid

64. Sbi-0207085.p001

65. Orbifloxacin 100 Microg/ml In Acetonitrile

66. O0516

67. D08299

68. D91881

69. O-2950

70. Ab00833179_04

71. Ab00833179_05

72. Orbifloxacin, Vetranal(tm), Analytical Standard

73. A803076

74. Orbifloxacin, Antibiotic For Culture Media Use Only

75. Q7100015

76. Sr-01000790054-2

77. Sr-01000790054-3

78. Brd-k63001556-001-03-9

79. Orbifloxacin, European Pharmacopoeia (ep) Reference Standard

80. Orbifloxacin, United States Pharmacopeia (usp) Reference Standard

81. 1-cyclopropyl-5,6,8-trifluoro-7-(cis-3,5-dimethyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid

82. 1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-5,6,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid

83. 1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-5,6,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid

84. 1-cyclopropyl-7-(cis-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

85. 1-cyclopropyl-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-quinoline-3-carboxylic Acid

86. 1-cyclopropyl-7-[(3r,5s)-3,5-dimethylpiperazin-4-ium-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylate

87. 1-cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-triluoro-4-oxoquinoline-3-carboxylic Acid

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 395.4 g/mol
Molecular Formula C19H20F3N3O3
XLogP30.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count3
Exact Mass395.14567599 g/mol
Monoisotopic Mass395.14567599 g/mol
Topological Polar Surface Area72.9 Ų
Heavy Atom Count28
Formal Charge0
Complexity691
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Emulsifying Agents

read-more
read-more

Topical

read-more
read-more

Solubilizers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Direct Compression

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

API Stability Enhancers

read-more
read-more

Taste Masking

read-more
read-more

Controlled & Modified Release

read-more
read-more

Parenteral

read-more
read-more

Co-Processed Excipients

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty